A comprehensive 2026 guide to UK online casinos with a 400% bonus. Understand wagering, find the best offers, and see if a 4x match is actually worth it. Read our full guide to 400% casino bonuses
CanSinoBIO’s NDA for Td5cp Adolescent and Adult Accepted, Further Strengthening Its Diversified Vaccine Pipeline
On August 16, 2026, CanSino Biologics Inc. (“CanSinoBIO”; HKEX: 06185/SHSE: 688185) announced that the New Drug Application (NDA) for its Tetanus, Reduced Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine,…
CanSinoBIO’s MCV4 Receives Registration Approval in Argentina, Further Expanding International Presence in South America
On June 25, CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company’s ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the “MCV4”, trade name: Menhycia(R)) has recently received the drug…
CTF Life Title Sponsors ‘Fencing Plus’ Training Programme 2026 Organised by Kai Tak Sports Initiative
– Selection Day and Kick-off Ceremony Successfully Held at KTSP Over 1,000 Children Registered to Experience the Joy of Fencing (Second from left) Man Kit Ip, Executive Director and CEO…
CanSinoBIO Delivers Q1 Revenue Growth Amid Accelerating International Expansion
CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled RMB 190 million, representing a 38.73% year-over-year increase. The performance highlights…
CanSinoBIO’s Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
CanSino Biologics Inc. (688185.SH/06185.HK) announced that the Company has obtained the Notification of Approval of Supplemental Drug Application issued by the National Medical Products Administration of China (the NMPA), pursuant…
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
In the first half of 2025, the structural transformation of the pharmaceutical industry continued to deepen. Driven by favorable policies, product upgrades, and technological innovation, the vaccine industry maintained a…